From Eggshell to Elixir: EFSA Declares Egg Membrane Collagen Peptides Safe for Adult Supplements

In a move that transforms kitchen waste into wellness gold, the European Food Safety Authority (EFSA) has officially endorsed egg membrane collagen peptides as a safe novel food—ushering in a new chapter for upcycled ingredients in the booming health supplement market. On December 3, 2025, EFSA’s Panel on Nutrition, Novel Foods and Food Allergens (NDA) concluded that this bioactive ingredient, derived from the delicate inner lining of chicken eggshells, poses no safety concerns when used as proposed.

Long discarded as byproduct in egg-processing facilities, the egg membrane is now being reimagined as a sustainable source of collagen peptides—short chains of amino acids prized for their potential roles in joint health, skin elasticity, and connective tissue support. The novel food in question is produced through enzymatic hydrolysis, a gentle, food-grade process that breaks down the membrane’s structural proteins into easily absorbable peptides. The final product contains 15% to 30% collagen peptides, with the remainder consisting of other naturally occurring components like glycoproteins and hyaluronic acid.

What stands out in EFSA’s assessment is not just approval—but confidence without caveats. Based on detailed data about the source (farmed chicken eggs), the well-characterized production method, and the composition of the final product, the panel determined that no toxicological studies were necessary—a rare and significant vote of confidence in the ingredient’s inherent safety.

The proposed use is precise: food supplements for adults, with a maximum daily dose of 500 mg, and explicit exclusion of pregnant and lactating women—a standard precaution for novel bioactives lacking pregnancy-specific data. This targeted application aligns with market trends, where collagen supplements already dominate shelves, but most are sourced from bovine hides or marine fish. Egg membrane offers a poultry-based, non-mammalian alternative, appealing to consumers seeking diverse or ethically sourced proteins.

Importantly, the production process sidesteps harsh chemicals or high-heat treatments, relying instead on controlled enzymatic cleavage, which preserves peptide integrity while ensuring microbiological safety. EFSA found the description of this process sufficiently detailed and free of red flags—a critical checkpoint for any novel food derived from animal byproducts.

While EFSA’s opinion focuses solely on safety—not efficacy—the green light paves the way for manufacturers to explore claims related to joint mobility or skin health, provided they meet separate regulatory requirements under EU nutrition and health claim legislation.

Beyond human health, this approval carries environmental resonance. By valorizing a traditionally wasted material, egg membrane collagen supports the circular economy in food production—turning millions of tons of shell waste into high-value nutraceuticals.

As Europe continues to embrace innovation rooted in sustainability and science, egg membrane collagen peptides stand as a quiet triumph: proof that sometimes, the most promising ingredients aren’t discovered in distant labs—but recovered from our own plates. And now, thanks to EFSA, they’re ready for the supplement bottle—safely, responsibly, and with full regulatory backing.